# Forensic Dossier: Study Forensics: Amyloid-targeting antibody improves biomarkers without cognitive benefit

**Run ID:** `full27_study-forensics-029_Claude_Opus_28a9e9`  
**Task:** study-forensics-029 | study_forensics | medium | study_forensics  
**Timestamp:** 2026-04-08T17:05:06.666433+00:00  
**Task Family:** solid  
**Trap Type:** borderline_solid_with_caveats  
**Ambiguity:** medium  

## Executive Summary

**Agents tested:** Claude Opus
**Winner:** Claude Opus — **64.8/100** (margin: 0.0)
**Failure modes:** decorative_uncertainty, missed_key_insight, unsupported_conclusion, unsupported_intermediate_step
**Forensic flags:** 4
**Consistency findings:** 5
**Answer convergence:** all agents agree

## Score Matrix

| Agent | Correctness | Support Strength | Structural Reaso | Assumption Disci | Uncertainty Hand | Alternative Hypo | Self Monitoring  | Insight Depth | Mechanism Qualit | Communication Ef | **Total** |
|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|
| Claude Opus | 30.0/30 | 0.0/8 | 4.8/8 | 4.8/6 | 3.6/6 | 6.0/6 | 1.6/8 | 4.0/8 | 0.0/10 | 10.0/10 | **64.8/100** |

## Study Forensics Audit

### Claude Opus

**Classification:** `solid` [+] (gold: `solid`)
**Finding Recall:** 50%
**Matched Findings:** cautious_scope_control
**Missed Findings:** evidence_matches_claim
**Extra Findings:** none_or_minor, conclusion_exceeds_results

## Reasoning Integrity Audit

### Claude Opus
**Classification:** Correct but brittle reasoning
**Load-bearing steps:** 0 / 6

## Mechanism Analysis

### Claude Opus
| Aspect | Status |
|--------|--------|
| Concept named | :x: none |
| Mechanism described | :x: (0 sentence(s)) |
| Grounded to case | :x: (0 sentence(s)) |

**Missing:** concept not named, mechanism not described, mechanism not grounded to case data

## Grounding Audit

### Claude Opus
Conclusion claims: 1
- Direct support: 0
- Indirect support: 0
- Unsupported: 1
- Contradicted: 0

**Unsupported claims:**
- "solid"


## Forensic Flags

### Claude Opus

- **[MODERATE]** `weak_mechanism`: Correct answer but weak mechanism explanation — answer may not generalize
  - `final_answer`: "solid"
- **[MAJOR]** `unsupported_leap`: Correct answer with weak support chain — final answer may be an unsupported leap
- **[MODERATE]** `unsupported_conclusion_claims`: 1/1 conclusion claims lack step support
  - `final_answer`: "solid"
- **[MINOR]** `study_forensics_overflagging`: Agent raised extra findings in solid case: none_or_minor, conclusion_exceeds_results


## Evidence Map

### Claude Opus

**Correctness:** 30.0/30
  - (+) `final_answer`: "solid"
    _Agent's answer for correctness check_
  - Note: Exact match

**Support Strength:** 0.0/8
  - (-) `final_answer`: "solid"
    _Conclusion not supported by steps_
  - Note: Support classification: 0 load-bearing, 0 supporting, 0 mentioned / 6
  - Note: Reasoning graph: conclusion not well grounded

**Structural Reasoning:** 4.8/8
  - (+) `steps[5]`: "Assessed whether claims exceed evidence: the text reports both positive (biomarkers) and negative (cognition) results ac"
    _Most informative reasoning step_
  - Note: 6 reasoning steps
  - Note: Low step utility: 0/6 steps contribute

**Assumption Discipline:** 4.8/6
  - (+) `assumptions[2]`: "The text accurately represents the study's findings and investigators' statements"
    _Most substantive assumption_
  - Note: 3/3 substantive assumptions

**Uncertainty Handling:** 3.6/6
  - (+) `uncertainties[0]`: "Whether the open-label extension proposal might be seen as implying eventual cognitive benefit"
    _Most substantive uncertainty_
  - (+) `confidence`: "confidence: 0.9"
    _Stated confidence level_
  - (-) `uncertainties[1]`: "The exact wording of the investigators' statements versus the summary provided"
    _Listed but never addressed in reasoning_
  - Note: 2 uncertainties (2 substantive)
  - Note: 1 decorative uncertainty(ies)

**Alternative Hypothesis Quality:** 6.0/6
  - (+) `alternative_hypotheses[0]`: "Considered overclaim if investigators were spinning the biomarker results as meaningful despite cognitive failure, but t"
    _Most substantive alternative hypothesis_
  - Note: 2 alternative hypotheses considered
  - Note: 2/2 include rejection reasoning

**Self Monitoring Quality:** 1.6/8
  - (+) `self_check[2]`: "The proposal for extension study is reasonable scientific practice, not overclaiming"
    _Most substantive self-verification step_
  - (-) `self_check[0]`: "Did not overflag - the text explicitly acknowledges the cognitive failure"
    _Fluff self-check_
  - Note: 3 self-check items
  - Note: Self-check quality: 0 deep, 1 arithmetic, 2 fluff

**Mechanism Quality:** 0.0/10
  - Note: Neither names concept nor explains mechanism

**Communication Efficiency:** 10.0/10
  - Note: Signal density: 0.71, 244 words

**Insight Depth:** 4.0/8
  - (?) `(not found)`: "Missing: appropriate scope"
    _Insight 'appropriate scope' not found_
  - Note: Key insights: 1 full / 2


## Failure Analysis

### Claude Opus

**MODERATE:**
- **Unsupported Conclusion** `[MEDIUM CONFIDENCE]`: Final answer lacks load-bearing or supporting step grounding
  - `final_answer`: "solid"
  - _Impacts: support_strength_
- **Unsupported Intermediate Step** `[MEDIUM CONFIDENCE]`: No reasoning step is load-bearing — final answer lacks traceable derivation
  - `final_answer`: "solid"
  - _Impacts: support_strength, structural_reasoning_
- **Missed Key Insight** `[MEDIUM CONFIDENCE]`: Missed expected finding: evidence_matches_claim
  - `(task expectation)`: "Expected: evidence_matches_claim"
  - _Impacts: insight_depth_

**STYLISTIC:**
- **Decorative Uncertainty** `[HEURISTIC]`: Uncertainty 'The exact wording of the investigators' statements versus th...' is listed but not addressed
  - `uncertainties[1]`: "The exact wording of the investigators' statements versus the summary provided"
  - _Impacts: uncertainty_handling_


## Consistency & Grounding Audit

### Claude Opus

- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 1 has low overlap with final answer (0/12 content words)
  - `key_claims[0]`: "This is an example of appropriate scientific communication: reporting both positive biomarker result"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 2 has low overlap with final answer (0/9 content words)
  - `key_claims[1]`: "The investigators acknowledge the key limitation (no cognitive benefit) despite the drug's biologica"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 3 has low overlap with final answer (0/6 content words)
  - `key_claims[2]`: "The text maintains appropriate skepticism about therapeutic value"
- **[WARN]** `[HEURISTIC]` `claim_step_alignment`: Key claim 3 not well supported in reasoning steps (1/6 content words found)
  - `key_claims[2]`: "The text maintains appropriate skepticism about therapeutic value"
- **[WARN]** `[HEURISTIC]` `decorative_uncertainty`: Uncertainty 2 appears decorative — not addressed in reasoning or self-check
  - `uncertainties[1]`: "The exact wording of the investigators' statements versus the summary provided"


## Agent Profiles

### Claude Opus (claude-opus-4-20250514)
**Parse OK:** True | **Latency:** 17220ms

**Final Answer:** solid

**Confidence:** 0.9

**Assumptions:**
- This is a Phase 2/3 trial with human participants
- The trial had cognitive decline as a primary or key endpoint
- The text accurately represents the study's findings and investigators' statements

**Reasoning Steps:**
1. Identified this as a clinical human trial (Phase 2/3) with inherited Alzheimer's patients
2. Noted the drug successfully cleared amyloid and improved neurodegeneration markers
3. Recognized the key finding: despite biomarker success, no cognitive benefit was shown
4. Evaluated the investigators' response: they emphasized biomarker impacts but explicitly acknowledged lack of cognitive benefits
5. Checked for evidence-tier mismatch: the evidence is from humans, conclusions are about the same human population
6. Assessed whether claims exceed evidence: the text reports both positive (biomarkers) and negative (cognition) results accurately

**Key Claims:**
- This is an example of appropriate scientific communication: reporting both positive biomarker results and negative clinical outcomes
- The investigators acknowledge the key limitation (no cognitive benefit) despite the drug's biological activity
- The text maintains appropriate skepticism about therapeutic value

**Alternative Hypotheses:**
- Considered overclaim if investigators were spinning the biomarker results as meaningful despite cognitive failure, but they acknowledged the limitation
- Considered mechanism_vs_evidence if they were implying future cognitive benefits from biomarker changes, but they only proposed further study

**Uncertainties:**
- Whether the open-label extension proposal might be seen as implying eventual cognitive benefit
- The exact wording of the investigators' statements versus the summary provided

**Self-Verification:**
- Did not overflag - the text explicitly acknowledges the cognitive failure
- The investigators are not making claims beyond their evidence
- The proposal for extension study is reasonable scientific practice, not overclaiming

**Dimension Scores:**
- Correctness: 30.0/30 `##########`
- Support Strength: 0.0/8 `..........`
- Structural Reasoning: 4.8/8 `######....`
- Assumption Discipline: 4.8/6 `########..`
- Uncertainty Handling: 3.6/6 `######....`
- Alternative Hypothesis Quality: 6.0/6 `##########`
- Self Monitoring Quality: 1.6/8 `##........`
- Insight Depth: 4.0/8 `#####.....`
- Mechanism Quality: 0.0/10 `..........`
- Communication Efficiency: 10.0/10 `##########`


## Final Verdict

**Solo run: Claude Opus** scored **64.8/100**.

**Best per dimension:**
- Correctness: Claude Opus (30.0/30)
- Support Strength: Claude Opus (0.0/8)
- Structural Reasoning: Claude Opus (4.8/8)
- Assumption Discipline: Claude Opus (4.8/6)
- Uncertainty Handling: Claude Opus (3.6/6)
- Alternative Hypothesis Quality: Claude Opus (6.0/6)
- Self Monitoring Quality: Claude Opus (1.6/8)
- Insight Depth: Claude Opus (4.0/8)
- Mechanism Quality: Claude Opus (0.0/10)
- Communication Efficiency: Claude Opus (10.0/10)

**Latency vs Quality:**

| Agent | Latency | Score | Points/sec |
|-------|---------|-------|------------|
| Claude Opus | 17.2s | 64.8/100 | 3.8 |

Failure modes observed: decorative_uncertainty, missed_key_insight, unsupported_conclusion, unsupported_intermediate_step.
